PCOS Symptoms: Signs Often Missed and How It’s Diagnosed

Polycystic ovary syndrome affects up to one in ten women of reproductive age, making it one of the most common hormonal conditions in women, yet research consistently finds that a majority of cases go undiagnosed, sometimes for years, and often only after a woman has seen multiple doctors. Part of the problem is how variable and easy to misattribute the symptoms are. In a significant and very recent development, the condition has also just received an official new name.

A New Name: PCOS Is Now Officially PMOS

As of May 2026, “Polycystic Ovary Syndrome” has been officially renamed “Polyendocrine Metabolic Ovarian Syndrome,” abbreviated PMOS, according to Johns Hopkins Medicine. The rename reflects a long-standing clinical criticism of the old name: many women with the condition don’t actually have visible ovarian cysts, and the old name overemphasized a feature that isn’t universal while underemphasizing the condition’s broader hormonal and metabolic nature. The hope among clinicians is that a more accurate name will support earlier recognition and diagnosis, since the old name itself may have contributed to both patient and provider confusion about what the condition actually involves. Because “PCOS” remains by far the more widely recognized and searched term during this transition, this article uses both terms interchangeably.

What PCOS (PMOS) Actually Is

At its core, the condition is a hormonal imbalance involving elevated androgens (often described as “male hormones,” though present in all women at lower levels), disrupted ovulation, and, in many cases, insulin resistance. The Rotterdam diagnostic criteria, the most widely used clinical standard, require any two of three features: irregular or absent ovulation, clinical or biochemical signs of elevated androgens, and polycystic-appearing ovaries on ultrasound. Critically, a woman doesn’t need all three, or even the ovarian cyst feature specifically, to meet criteria, which is precisely the source of the naming confusion the 2026 rename is meant to address. The condition also varies considerably in severity and presentation from person to person, which is part of why clinicians increasingly describe it as a spectrum rather than a single uniform diagnosis, and why two women with the same official diagnosis can have very different day-to-day symptoms and treatment needs.

Why So Many Cases Go Undiagnosed

Several factors converge to delay diagnosis. Symptoms vary enormously between individuals: one woman might have significant weight gain and visible excess hair growth, while another has normal weight, no visible hyperandrogenism, and only subtle cycle irregularity, yet both may meet the same clinical criteria. Symptoms also overlap heavily with other conditions, including thyroid disorders, adrenal issues, and perimenopause, which can lead to misdiagnosis or a prolonged diagnostic search. Weight bias in healthcare settings is a specifically documented issue: leaner women with PCOS are frequently overlooked because the condition is popularly associated with weight gain, even though it occurs across all body sizes. And because irregular periods are also normal during the first year after a girl starts menstruating and during perimenopause, symptom onset around either of those life stages can be dismissed as expected rather than investigated.

Commonly Missed Signs

• Irregular cycles without other obvious symptoms. A woman can have disrupted ovulation and irregular periods without significant acne, weight change, or visible excess hair growth, and this presentation is easy to dismiss as “normal” cycle variation.
• Persistent acne into adulthood, particularly along the jawline, that doesn’t respond well to standard topical treatments, can be a sign of an underlying hormonal driver rather than a purely dermatologic issue.
• Scalp hair thinning in a male-pattern distribution (receding at the temples, thinning at the crown) is a less commonly recognized sign of elevated androgens compared to excess facial or body hair.
• Persistent fatigue and mood symptoms, including anxiety and depression, are common in PCOS/PMOS but are frequently treated as standalone mental health concerns without investigating a possible hormonal or insulin-resistance connection.
• Difficulty losing weight despite consistent effort can be a metabolic sign of underlying insulin resistance rather than a purely behavioral issue, though this varies significantly between individuals.
• Pelvic or abdominal pain, an underexplored but increasingly studied symptom area, is reported by a meaningful share of women with the condition but isn’t part of the classic symptom list most people associate with it.

A provider experienced in PCOS/PMOS care can help connect scattered symptoms that might otherwise be dismissed individually. Photo: Pexels

How Diagnosis Actually Works

Diagnosis is based on the Rotterdam criteria described above: two of three features (irregular ovulation, clinical or lab evidence of elevated androgens, or polycystic-appearing ovaries on ultrasound), after ruling out other conditions that can mimic PCOS/PMOS, such as thyroid disorders or, rarely, hormone-secreting tumors. There is no single blood test that definitively diagnoses the condition on its own; diagnosis typically involves a combination of a detailed symptom and cycle history, blood tests for androgen levels and related hormones, and often a pelvic ultrasound, sometimes alongside a test for anti-Müllerian hormone (AMH), which tends to run higher in PCOS/PMOS. Clinicians increasingly emphasize that the specific label matters less than identifying and addressing the individual pattern of symptoms and associated health risks a particular woman has, rather than treating diagnosis as a single yes-or-no checkbox.

How PCOS/PMOS Is Typically Managed

Treatment is individualized based on a woman’s specific symptoms, health risks, and goals, particularly whether she’s currently trying to conceive. Lifestyle-focused approaches, including regular exercise, a balanced diet with attention to blood sugar management, and weight management where relevant, are commonly recommended as a foundation, since they can improve insulin sensitivity and, for some women, help regulate ovulation. Hormonal birth control is frequently prescribed to regulate cycles and reduce androgen-related symptoms like acne and excess hair growth in women who are not currently trying to conceive. Metformin, a medication that improves insulin sensitivity, is commonly used, particularly for women with clear insulin resistance. For women trying to conceive, ovulation-inducing medications are often the first-line approach, and most women with PCOS/PMOS who don’t conceive through lifestyle changes and first-line medication alone still have good outcomes with further fertility treatment if needed, given that egg reserve itself is typically not reduced by the condition. Because treatment approaches differ so much depending on individual symptoms and goals, working with a doctor experienced specifically in PCOS/PMOS care, rather than general primary care alone, often leads to a more tailored and effective plan.

Why Early Diagnosis Matters

Beyond symptom relief, PCOS/PMOS carries meaningfully elevated long-term risk for type 2 diabetes, high blood pressure, cardiovascular disease, and endometrial cancer if the underlying hormonal and metabolic pattern goes unaddressed for years. Research has also found significant workplace and quality-of-life impact: in one large survey of over a thousand women with a physician-confirmed diagnosis, roughly half reported missing work because of the condition, and more than 70% felt it affected the quality of their work. Earlier diagnosis consistently correlates with better outcomes across reproductive health, metabolic health, and day-to-day quality of life, which is the central argument clinicians make for taking a cluster of seemingly unrelated symptoms seriously enough to investigate rather than dismiss individually.

Frequently Asked Questions

Why was PCOS renamed to PMOS?

The rename to Polyendocrine Metabolic Ovarian Syndrome, effective May 2026 according to Johns Hopkins Medicine, was made to more accurately reflect the condition, since many women with it don’t have visible ovarian cysts, and the old name was seen as contributing to diagnostic confusion by overemphasizing a non-universal feature.

Can you have PCOS without visible cysts on your ovaries?

Yes. Diagnosis under the Rotterdam criteria requires any two of three features: irregular ovulation, elevated androgens, or polycystic-appearing ovaries. A woman can be diagnosed based on the first two criteria alone, without the ovarian cyst feature, which is part of why the condition’s name has been considered misleading.

Is PCOS only a concern for fertility?

No. While PCOS/PMOS is a common cause of ovulation-related infertility, it also carries increased long-term risk for type 2 diabetes, cardiovascular disease, high blood pressure, and endometrial cancer, making it a broader metabolic and hormonal health concern beyond fertility alone.

What’s the first step if I think I might have PCOS/PMOS?

Start by tracking your cycle length and any symptoms you’ve noticed (acne, hair changes, weight patterns, fatigue) for a few months, then bring that information to a doctor, ideally an OB-GYN or endocrinologist with specific experience in the condition, who can order appropriate bloodwork and an ultrasound if needed.

References:

• Polyendocrine Metabolic Ovarian Syndrome (PMOS) — Johns Hopkins Medicine
• PCOS: Why Symptoms Matter More Than a ‘Label’ — Yale Medicine
• Productivity loss due to PCOS and healthcare delivery — peer-reviewed study